Skip to main content

Table 2 Comparison of clinical data between patients with no/mild and advanced fibrosis

From: Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)

Variable normal values Fibrosis 0-2 (n = 88) Fibrosis 3-4 (n = 15) p
Age (years) 45.0 ± 12.0 53.0 ± 9.0 P = 0.028
BMI (19-25 kg/m2) 29.5 ± 3.61 30.79 ± 4.90 P = 0.221
AST (<38 IU/L) 52.73 ± 33.36 69.20 ± 45.18 P = 0.097
ALT (<41IU/L) 91.60 ± 56.94 61.53 ± 37.25 P = 0.052
AST/ALT ratio 0.69 ± 0.56 1.32 ± 0.57 P < 0.001
Glucose (3.89-5.83 mmol/L) 5.5 ± 1.08 6.99 ± 1.98 P = 0.011
Insulin (41.7-187.5 pmol/L) 132 ± 184 249.3 ± 148.6 P = 0.037
PLT (150-400x109/L) 226.6 ± 61,9 192.3 ± 63.9 P = 0.051
Albumin (34-48 g/L) 43 ± 4.0 43 ± 4.0 P = 0.842
HBA1c (4.8-5.9%) 5.8 ± 1.0 7.5 ± 1.8 P = 0.108
HOMA (<1.8) 4.6 ± 6.2 12.2 ± 9.8 P = 0.030